期刊文献+

卫生技术评估在医疗服务价格项目管理中的应用 被引量:6

Application of Health Technology Assessment in Medical Service Pricing Project Management
下载PDF
导出
摘要 基于我国医疗服务价格项目管理现状,对卫生技术评估在医疗服务价格项目申报、定价与调整、医保准入和支付标准确定中的应用进行深入探讨。卫生技术评估(Health Technology Assessment,HTA)作为一项决策支持工具,能够为医疗服务价格项目的定价(包括后期确定医保准入和支付标准)提供循证依据,并有望成为解决我国医疗服务价格项目定价方式单一、医保准入缺乏全面证据、更新慢、价格调整频率低等问题的一个路径。为了进一步发挥卫生技术评估在医疗服务价格项目管理中的功能,还需继续强化各方对HTA认识,提高HTA能力,利用大数据解决HTA难题。 Based on the current situation of medical service price project management in China,the application of health technology assessment in medical service price project declaration,pricing and adjustment,medical insurance access and payment standard determination is deeply discussed.As a decision support tool,Health Technology Assessment(HTA)can provide evidence-based basis for the pricing of medical service price items(including the later determination of medical insurance access and payment standards),and is expected to become a solution to Chinese medical service price items problems,such as single pricing method,lack of comprehensive evidence for medical insurance access,slow update,and low frequency of price adjustment.To further play the role of health technology assessment in the management of medical service price projects,it is necessary to continue to strengthen the understanding of HTA,improve HTA capabilities,and use big data to solve HTA problems.
作者 吕兰婷 傅金澜 Lü Lanting;Fu Jinlan(School of Public Administration,Renmin University of China,Beijing,100872,China;不详)
出处 《中国医院管理》 北大核心 2022年第7期39-42,共4页 Chinese Hospital Management
基金 中国人民大学公共健康与疾病预防控制交叉学科重大创新平台成果(2021PDPC)。
关键词 医疗服务项目 卫生技术评估 经济性评价 定价 medical service item Health Technology Assessment economic evaluation pricing
  • 相关文献

参考文献9

二级参考文献50

  • 1人民网.重庆医疗调价实施7天后喊停[EB/OL].(2015-04-02)[2015-04-06].http://politics.people.com.cn.
  • 2Christensen S. Effects of selected fee schedule options on physicians' Medicare receipts[J]. Health Care Financ Rev, 1987, 9(2): 25–37.
  • 3American Medical Association. Overview of the RBRVS[EB/OL]. [2016-01-02].http://www.ama-assn.org/ama/pub/physician-resources/solutions-managing-your-practice/coding-billing-insurance/medicare/the-resource-based-relative-value-scale/overview-of-rbrvs.page.
  • 4American Medical Association. Relative values for physicians[M]. Salt Lake City: Optuminsight, 2013.
  • 5Fillinger M, Zwolak R, Musson A, et al. Vascular laboratory cost analysis and the impact of the Resource-Based Relative Value Scale payment system[J]. Journal of Vascular Surgery, 1993, 17(2): 267–279.
  • 6Wolman D, Kalfoglou A, LeRoy L. Medicare laboratory payment policy: Now and in the future[M]. Washington D C: National Academy Press, 2000.
  • 7Takemura Y, Ishida H, Inoue Y, et al. Common Diagnostic Test Panels for ClinicalEvaluation of New Primary Care Outpatients inJapan: A Cost-Effectiveness Evaluation[J]. Clinical Chemistry, 1999, 45(10): 1752–1761.
  • 8Department of Health, Australian Government. Australian Government HTA Processes[EB/OL]. [2016-01-02]. http://www.health.gov.au/internet/hta/publishing.nsf/Content/commonwealth-1.
  • 9Mesaros T, Mesarosova A, Kucharovic B. Economic Impact of Genetic Diagnostic Test For Breast Cancer- Health Technology Assessment in Slovak Health Care Environment[J]. Value in Health, 2014, 17(7): A739.
  • 10World Bank. ICP handbook[EB/OL]. [2016-01-05].http://web.worldbank.org/WBSITE/EXTERNAL/DATASTATISTICS/ICPEXT/0,contentMDK:22407349~pagePK:60002244~piPK:62002388~theSitePK:270065,00.html.

共引文献184

同被引文献64

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部